Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004450776 | SCV004946426 | uncertain significance | not specified | 2023-12-07 | criteria provided, single submitter | clinical testing | The c.755A>G (p.D252G) alteration is located in exon 2 (coding exon 2) of the SEMG1 gene. This alteration results from a A to G substitution at nucleotide position 755, causing the aspartic acid (D) at amino acid position 252 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |